Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  HEXO Corp.    HEXO   CA4283041099

HEXO CORP.

(HEXO)
  Report  
Delayed Quote. Delayed Toronto Stock Exchange - 10/11 04:48:39 pm
3.35 CAD   -10.90%
10/11TSX set to rise for third day on trade deal hopes, strong jobs data
RE
10/10GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
10/10TSX rises 0.26 percent to 16,422.68
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CAD 2.32 CAD in weekly data.
  • The close medium term support offers good timing for purchasing the stock.
  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • The company has insufficient levels of profitability.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Analysts covering the stock have recently lowered their earnings forecast.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • The underlying tendency is negative on the weekly chart below the resistance at 6.1 CAD
Ratings chart
Sector Alternative Medicine
1st jan.Capitalisation (M$)Investor Rating
HEXO CORP.-20.17%654
CANOPY GROWTH CORPORATION-25.81%6 779
BEIJING TONGRENTANG CO., LT..-2.55%5 187
AURORA CANNABIS INC.-26.84%3 796
CURALEAF HOLDINGS, INC.25.39%2 852
-
DONG-E-E-JIAO CO LTD--.--%2 788
CRONOS GROUP INC.-26.43%2 646
HUTCHISON CHINA MEDITECH LI..0.00%2 297
CHARLOTTE'S WEB HOLDINGS, I..15.82%1 298
-
INDUSTRI JAMU DAN FARMASI S..--.--%1 266
TONG REN TANG TECHNOLOGIES ..-28.52%1 212
APHRIA INC0.00%1 188
TRULIEVE CANNABIS CORP.13.00%1 098
-
HARVEST HEALTH & RECREATION..-53.19%739
-
BOIRON-35.65%610
ORGANIGRAM HOLDINGS INC0.00%494
More Results
Financials (CAD)
Sales 2019 49,2 M
EBIT 2019 -48,4 M
Net income 2019 -37,0 M
Finance 2019 180 M
Yield 2019 -
P/E ratio 2019 -18,7x
P/E ratio 2020 -115x
EV / Sales2019 13,8x
EV / Sales2020 3,30x
Capitalization 861 M
Upcoming event on HEXO CORP.
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality -
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes